Importantly, C-reactive protein (CRP), a key inflammatory marker, was markedly lower in the COVID-19 group (26.0 vs. 47.8 mg/dL, p < 0.001), suggesting a milder inflammatory response at presentation. This evidence concerns the gene CRP and COVID-19.